VIE/VEEV (VIE/VEEV)

Vienna Stock Exchange: VIE/VEEV · EUR

€283

+1.60 (+0.6%)· Recorded snapshot

Market cap	46.2B
Revenue (ttm)	3B
Net income (ttm)	882.1M
EPS (ttm)	€5.47
P/E (trailing)	51.8x
P/E (forward)	32.3x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3B
Net income (ttm): 882.1M
EPS (ttm): €5.47
P/E (trailing): 51.8x
P/E (forward): 32.3x
Market cap: 46.2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E32.3

P25 n/aP50 n/aP75 n/a

Trailing P/E51.8

P25 n/aP50 n/aP75 n/a

ROE14.4

P25 n/aP50 n/aP75 n/a

ROIC95.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/VEEV indicators

Market & fundamental data

Available fields

227

Groups with data

Currency

USD

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	AT
Earnings date	2026-12-02
Employees	7,928
Employees change	119
Employees growth	1.66%
Enterprise value	EUR 39.8B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-07-31
First seen	2026-05-10
Fiscal year end	January
Founded	2007
Industry	Health Information Services
Is primary listing	No
ISIN number	US9224751084
Last earnings date	2026-08-26
Last refreshed	2026-10-29
Market cap	EUR 46.2B
Next earnings date	2026-12-02
Price	EUR 283.20
Price currency	EUR
Sector	Healthcare
SIC code	7370
Stock price date	2026-10-28
Symbol	vie/VEEV
Website	https://www.veeva.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	71x
Average P/E ratio (3Y)	48.61x
Average P/E ratio (5Y)	58.65x
Earnings yield	1.93%
EV/Earnings	45.12x
EV/EBIT	42.87x
EV/EBITDA	40.5x
EV/FCF	27.94x
EV/Sales	12.83x
FCF / EV yield	3.58%
FCF yield	3.09%
Forward P/E	32.26x
Graham number	69.45989
Graham upside	-75.47%
Lynch fair value	EUR 103.10
Lynch upside	-63.6%
P/(FCF - SBC) ratio	46.42x
P/(OCF - SBC) ratio	45.36x
P/B ratio	7.15x
P/E ratio	51.76x
P/FCF ratio	32.41x
P/OCF ratio	31.89x
P/S ratio	15.36x
Price / tangible book value	7.72x
Price/EBITDA ratio	49.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	29.93%
EBITDA margin	31.1%
Effective tax rate	23.55%
FCF margin	45.93%
Gross margin	74.96%
Operating margin	29.93%
Pretax margin	38.38%
Profit margin	29.34%
Profit per employee	EUR 111,269
Profitable quarters	56
Profitable years	16
Revenue per employee	EUR 379,178
ROA	7.58%
ROA (5Y)	6.94%
ROCE	13.61%
ROE	14.42%
ROE (5Y)	14.27%
ROIC	95.58%
ROIC (5Y)	72.98%
SBC / revenue	14.3%
Tax / revenue	9.04%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	25.52%
EPS growth (Q)	39.5%
EPS growth (QoQ)	5.73%
EPS growth 10Y	32.35%
EPS growth 3Y	22.48%
EPS growth 5Y	18.41%
EPS growth quarters	10
EPS growth years	14
FCF growth	23.4%
FCF growth (Q)	-0.62%
FCF growth (QoQ)	-79.5%
FCF growth 3Y	19.72%
FCF growth 5Y	16.93%
Gross profit growth	15.53%
Gross profit growth (Q)	17.2%
Gross profit growth 3Y	17.98%
Gross profit growth 5Y	16.49%
Net income growth	25.29%
Net income growth (Q)	36.5%
Net income growth (QoQ)	4.79%
Net income growth 3Y	23.39%
Net income growth 5Y	19.05%
Net income growth quarters	10
Net income growth years	15
OCF growth	23.44%
OCF growth (Q)	0.12%
OCF growth (QoQ)	-78.82%
OCF growth 10Y	27.71%
OCF growth 3Y	19.46%
OCF growth 5Y	16.95%
Operating income growth	24.68%
Operating income growth (Q)	21.4%
Operating income growth 3Y	37.75%
Operating income growth 5Y	17.95%
Revenue growth	16.5%
Revenue growth (Q)	17.6%
Revenue growth (QoQ)	5.1%
Revenue growth 10Y	22.03%
Revenue growth 3Y	15.71%
Revenue growth 5Y	15.76%
Revenue growth quarters	52
Revenue growth years	15

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -23.2M
Depreciation and amortization	EUR 36.3M
EBIT	EUR 899.6M
EBITDA	EUR 934.8M
EPS	EUR 5.47
Financing cash flow	EUR -580M
Free cash flow	EUR 1.4B
Free cash flow minus SBC	EUR 994.6M
Gross profit	EUR 2.3B
Income taxes	EUR 271.8M
Investing cash flow	EUR -969.5M
Net cash flow	EUR -102.8M
Net income	EUR 882.1M
Operating cash flow minus SBC	EUR 1B
Operating income	EUR 899.6M
Revenue	EUR 3B
Stock-based compensation	EUR 429.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	15.64
Book value per share	EUR 39.92
Debt / EBITDA	0.14
Debt / equity	0.02
Debt / FCF	0.09
Goodwill	EUR 442.2M
Long-term assets	EUR 748.6M
Long-term liabilities	EUR 110M
Net cash (debt)	EUR 6.2B
Net cash / market cap	13.35%
Net cash growth	12.23%
Net debt / EBITDA	-6.59
Net debt / equity	-0.95
Net debt / FCF	-4.33
Piotroski F-Score	4
Property, plant and equipment	EUR 187.3M
Shareholders' equity	EUR 6.5B
Tangible book value	EUR 6B
Tangible book value per share	EUR 36.97
Total assets	EUR 7.9B
Total cash	EUR 6.3B
Total debt	EUR 131.9M
Total liabilities	EUR 1.4B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.41
Current assets	EUR 7.1B
Current liabilities	EUR 1.3B
Current ratio	5.46
Net working capital	EUR -641.6M
Quick ratio	5.36
Working capital	EUR 5.6B
Working capital turnover	0.49

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.14%
Shareholder yield	0.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 185.59
1D price change	0.57%
1M price change	15.69%
1M total return	15.69%
1W price change	-0.39%
1W total return	-0.39%
1Y price change	11.58%
1Y return CAGR	11.59%
1Y total return	11.58%
20-day SMA	EUR 268.56
200-day SMA	EUR 179.96
3M price change	64.6%
3M total return	64.6%
3Y price change	56.03%
3Y return CAGR	15.98%
3Y total return	56.03%
50-day SMA	EUR 246.18
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 289.00
52-week high date	2026-10-23
52-week low	EUR 128.20
52-week low date	2026-04-10
6M price change	104.7%
6M total return	104.7%
All-time high	EUR 289.00
All-time high date	2026-10-23
All-time low	EUR 128.20
All-time low date	2026-04-10
Average true range (ATR)	EUR 5.23
Average volume	0.8
Change from 52-week high	-2.01%
Change from 52-week low	120.91%
Change from all-time high	-2.01%
Change from all-time low	120.9%
Change from open	1.07%
Day's gap	-0.5%
High price	EUR 283.20
Low price	EUR 277.30
Monthly RSI	66.61
Open price	EUR 280.20
Position in 52-week range	100%
Previous close	EUR 281.60
Price vs 150-day SMA	52.59%
Price vs 20-day SMA	5.45%
Price vs 200-day SMA	57.37%
Price vs 50-day SMA	15.04%
Relative volume	2.42
RSI	69.93
Sharpe ratio	0.38
Sharpe ratio (3Y)	0.49
Sortino ratio	0.71
Sortino ratio (3Y)	0.9
Weekly RSI	74.53
YTD price change	47.85%
YTD total return	47.85%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	148.3M
Shares change (QoQ)	-0.56%
Shares change (YoY)	-0.14%
Shares held by insiders	8.32%
Shares held by institutions	90.53%
Short ratio	2.5 days

Deeper analysis on VIE/VEEV

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/VEEV report

Is a complete VIE/VEEV research report available?

No complete published report is available for vie/VEEV (VIE/VEEV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/VEEV (VIE/VEEV)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/VEEV

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All VIE/VEEV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/VEEV

Frequently asked questions